Bildkälla: Stockfoto

Active Biotech: Rights Issue Subscribed to 85% - Redeye

Redeye comments on the result of Active Biotech's rights issue.

Redeye comments on the result of Active Biotech's rights issue.
Börsvärldens nyhetsbrev
ANNONSER